Filing Details

Accession Number:
0001179110-13-017041
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-26 06:53:12
Reporting Period:
2013-11-25
Filing Date:
2013-11-26
Accepted Time:
2013-11-26 06:53:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1360886 Osiris Therapeutics Inc. OSIR Biological Products, (No Disgnostic Substances) (2836) 710881115
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1280180 Jr R Philip Jacoby 7015 Albert Einstein Drive
Columbia MD 21046
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Commonstock Acquisiton 2013-11-25 3,749 $6.46 16,249 No 4 M Direct
Commonstock Acquisiton 2013-11-25 9,624 $7.13 25,873 No 4 M Direct
Common Stock Acquisiton 2013-11-25 4,999 $5.08 30,872 No 4 M Direct
Common Stock Disposition 2013-11-25 18,372 $15.99 12,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-11-25 3,749 $6.46 3,749 $6.46
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-11-25 9,624 $7.13 9,624 $7.13
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-11-25 4,999 $5.08 4,999 $5.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
109,751 2011-05-27 2020-05-27 No 4 M Direct
100,127 2012-02-14 2021-02-14 No 4 M Direct
95,128 2013-03-23 2022-03-23 No 4 M Direct